✦ LIBER ✦

Epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in FIGO stage IIIB. A phase II study

✍ Scribed by Myrna Candelaria; Lucely Cetina; Alicia Garcia; Talia Wegman-Ostrosky; Elizabeth Robles; Aurora González-Fierro; Carlos López-Graniel; Aaron González; David Cantú; Lesbia Ribera; Lucia Taja-Chayeb; Catalina Trejo-Becerril; Enrique Pérez-Cárdenas; Carlos Pérez-Plasencia; Alma Chavez-Blanco; Alfonso Dueñas-González

Book ID: 115011188
Publisher: BioMed Central
Year: 2007
Tongue: English
Weight: 164 KB
Volume: 7
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-7-s1-a28

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of epigenetic therapy w

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

✍ Myrna Candelaria; Dolores Gallardo-Rincón; Claudia Arce; Lucely Cetina; Jose Lui 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 164 KB

A phase II study with vinorelbine, gemci

A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb–IV non-small cell lung cancer (NSCLC)

✍ Ginopoulos, P.; Mastronikolis, N.S.; Giannios, J.; Karana, A.; Siabi, V.; Karvel 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Long-Term Survival with Concurrent Chemo

Long-Term Survival with Concurrent Chemoradiation Therapy Followed by Consolidation Docetaxel in Stage IIIB Non–Small-Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S9504)

✍ David R. Gandara; Kari Chansky; Kathy S. Albain; Laurie E. Gaspar; Primo N. Lara 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 141 KB

Phase II study of cisplatin, ifosfamide,

Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer

✍ Fujita, A; Ohkubo, T; Hoshino, H; Takabatake, H; Tagaki, S; Sekine, K; Abe, S 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

Fractionated administration of cisplatin

Fractionated administration of cisplatin (CDDP) and irinotecan (CPT-11) in patients with stage IIIB and IV non-small-cell lung cancer (NSCLC): A phase II study

✍ Takata, I; Ueoka, H; Kiura, K; Hiraki, S; Eguchi, K; Okimoto, N; Harita, S; Yone 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Gemcitabine and cisplatin as induction c

Gemcitabine and cisplatin as induction chemotherapy in stage IIIAN2/IIIB Non Small Cell Lung Cancer (NSCLC). A mono-institutional phase II study with 21 days schedule

✍ Migliorino, M; De Marinis, F; Nelli, F; Facciolo, F; Ammaturo, M.V; Ramponi, S; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB